genworth financial inc. - GNW
GNW
Close Chg Chg %
7.05 0.17 2.41%
Closed Market
7.22
+0.17 (2.41%)
Volume: 7.77M
Last Updated:
May 12, 2025, 3:59 PM EDT
Company Overview: genworth financial inc. - GNW
GNW Key Data
Open $7.23 | Day Range 7.11 - 7.31 |
52 Week Range 5.87 - 7.90 | Market Cap $2.92B |
Shares Outstanding 414.46M | Public Float 405.39M |
Beta 1.00 | Rev. Per Employee N/A |
P/E Ratio 14.31 | EPS $0.50 |
Yield 0.00% | Dividend $0.10 |
EX-DIVIDEND DATE Oct 8, 2008 | SHORT INTEREST N/A |
AVERAGE VOLUME 6.98M |
GNW Performance
1 Week | 2.27% | ||
1 Month | 10.24% | ||
3 Months | -1.10% | ||
1 Year | 8.91% | ||
5 Years | 167.04% |
GNW Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
2
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
Average Recommendation | HOLD | Average Target Price | 8.00 | |
Number of Ratings | 2 | Current Quarters Estimate | 0.05 | |
FY Report Date | 06 / 2025 | Current Year's Estimate | 0.70 | |
Last Quarter’s Earnings | 0.12 | Median PE on CY Estimate | N/A | |
Year Ago Earnings | 0.62 | Next Fiscal Year Estimate | 0.43 | |
Median PE on Next FY Estimate | N/A |
Earnings Per Share
This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
---|---|---|---|---|
# of Estimates | 1 | N/A | 2 | 1 |
Mean Estimate | 0.05 | N/A | 0.70 | 0.43 |
High Estimates | 0.05 | N/A | 1.10 | 0.43 |
Low Estimate | 0.05 | N/A | 0.30 | 0.43 |
Coefficient of Variance | N/A | N/A | 80.81 | N/A |
Analysts Recommendations
Current | 1 Month Ago | 3 Months Ago | |
---|---|---|---|
BUY | 0 | 0 | 0 |
OVERWEIGHT | 0 | 0 | 0 |
HOLD | 2 | 2 | 1 |
UNDERWEIGHT | 0 | 0 | 0 |
SELL | 0 | 0 | 0 |
MEAN | Hold | Hold | Hold |
SEC Filings for Genworth Financial Inc. - GNW
Filing Date | Type | Category | Amended |
---|---|---|---|
No results |
Insider Actions for Genworth Financial Inc. - GNW
Date | Name | Shares | Transaction | Value |
---|---|---|---|---|
Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 117,467 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 110,930 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 737,684.50 |
Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 56,259 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 88,804 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 75,949 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 54,289 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Samir B Shah Pres. & CEO, CareScout Svcs. | 112,518 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 315,846 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 2,100,375.90 |
Mar 3, 2025 | Gregory S. Karawan EVP and General Counsel | 323,379 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 70,323 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 3, 2025 | Melissa Hagerman EVP and Chief HR Officer | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 82,267 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 547,075.55 |
Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 112,518 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 86,862 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 410,240 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $6.65 per share | 2,728,096.00 |
Mar 3, 2025 | Jerome T. Upton EVP & Chief Financial Officer | 421,867 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 648,638 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Andrea Lynn White Pres. & CEO, CareScout Ins. | 43,432 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
Mar 3, 2025 | Mark Blakeley Hodges EVP and Chief Risk Officer | 56,259 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |